Pages that link to "Q39639586"
Jump to navigation
Jump to search
The following pages link to Serum levels and genotype distribution of α1-antitrypsin in the general population (Q39639586):
Displaying 38 items.
- Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes (Q26861561) (← links)
- SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort (Q28387428) (← links)
- Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels (Q31129874) (← links)
- A reference panel of 64,976 haplotypes for genotype imputation (Q33553419) (← links)
- Common coding variant in SERPINA1 increases the risk for large artery stroke (Q33556760) (← links)
- α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy (Q34428735) (← links)
- Identification and characterisation of eight novel SERPINA1 Null mutations (Q34630059) (← links)
- Imputation of variants from the 1000 Genomes Project modestly improves known associations and can identify low-frequency variant-phenotype associations undetected by HapMap based imputation (Q34734140) (← links)
- Targeted biomarker discovery by high throughput glycosylation profiling of human plasma alpha1-antitrypsin and immunoglobulin A. (Q34988803) (← links)
- How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency? (Q35745026) (← links)
- Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis (Q38581002) (← links)
- Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database (Q38604669) (← links)
- Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies (Q38797163) (← links)
- Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency (Q38988633) (← links)
- Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline (Q39241260) (← links)
- PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD. (Q41614676) (← links)
- A novel alpha1-antitrypsin null variant (PiQ0Milano ). (Q41888088) (← links)
- Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency (Q42656500) (← links)
- Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine (Q49961017) (← links)
- European screening for alpha1 -antitrypsin deficiency in subjects with lung disease (Q51636248) (← links)
- Advances in managing COPD related to α -antitrypsin deficiency: An under-recognized genetic disorder (Q56243502) (← links)
- Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites (Q58618636) (← links)
- The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins (Q59356531) (← links)
- Update on α-antitrypsin deficiency (Q61044333) (← links)
- S-Nitrosylation of α1-Antitrypsin Triggers Macrophages Toward Inflammatory Phenotype and Enhances Intra-Cellular Bacteria Elimination (Q64084582) (← links)
- Evaluation of alpha-1-antitrypsin levels in blood serum of patients with chronic obstructive pulmonary disease (Q64241516) (← links)
- Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand (Q89588291) (← links)
- New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency (Q89907121) (← links)
- Clinical considerations in individuals with Alpha-1 Antitrypsin PI*SZ genotype (Q90280101) (← links)
- Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology (Q90385913) (← links)
- Clarifying the Risk of Lung Disease in SZ α1-antitrypsin Deficiency (Q90515735) (← links)
- Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence (Q91671251) (← links)
- Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology (Q91827802) (← links)
- Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency (Q91894737) (← links)
- Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians (Q92032662) (← links)
- Haplotype in SERPINA1 (AAT) Is Associated with Reduced Risk for COPD in a Mexican Mestizo Population (Q92353531) (← links)
- Functional characterization of a SNP (F51S) found in human alpha 1-antitrypsin (Q93101948) (← links)
- Aggregation of M3 (E376D) variant of alpha1- antitrypsin (Q95300256) (← links)